2025 ASCP Buyer’s GUIDE
Sun Pharma
www.sunpharma.com/usa
Sun Pharma is a leading global pharmaceutical
company with specialty and generic presence in
the world’s largest pharma markets. The Company
has solidified its position as a major player in the
U.S. generics market and is continuously expanding
its footprint in the specialty segment, focusing
on dermatology, ophthalmology, and oncology.
Teva Medical Affairs
tevamedical.com
Teva Medical strives to provide access to educational
resources, clinical/scientific information, and
resources designed to advance the exchange
of information regarding Teva’s medicines and
therapeutic areas with the medical community.
Teva Pharmaceuticals
www.tevapharm.com
Teva Pharmaceutical Industries Ltd. has been
developing and producing medicines to improve
people’s lives for more than a century. We offer
generic, biosimilars and innovative medicines
with a portfolio consisting of over 3,600
products in nearly every therapeutic area.
Thirdwave Rx
www.thirdwaverx.com
Thirdwave RX brings healthcare providers unrivaled
savings by combining our industry expertise with
advanced automation. Healthcare, pharmacy,
and financial professionals work with purpose-
built technology to create a highly compliant
solution that enables providers to achieve their
lowest net drug cost. We deliver our customers
guaranteed rebates on time, every time.
UCB
www.ucb-usa.com
At UCB, we are driven to improve the lives of people
living with epilepsy and rare syndromes. For more
than 30 years, we have provided solutions that
have helped transform the epilepsy landscape and
improved the lives of millions of people. As leaders
in the field it is our responsibility to find new ways
to evolve the treatment landscape with a focus
on moving from seizure symptoms to disease
modification. The epilepsy and rare syndromes
community is at the heart of everything we do,
and our commitment has never been stronger.
VaxServe
www.vaxserve.com
VaxServe is your trusted source for customized
ordering, business management tools, and training
and educational resources. It’s everything your
business needs, all in one place. And as a leading
distributor of vaccines, VaxServe not only gives you
access to many trusted brands, but expert support
and personalized service every step of the way.
We are tirelessly committed to solutions that
deliver a healthier, more resilient community.
Viatris
www.viatris.com
Viatris is a global healthcare company uniquely
positioned to bridge the traditional divide between
generics and brands, combining the best of both to
more holistically address global healthcare needs.
With a mission to empower people worldwide to live
healthier at every stage of life, we provide access at
scale — supplying medicines to approximately
1 billion patients around the world.
VMI Care
www.vmi-care.com
Precisely the right medication for each intake
moment during the day. VMI’s smart machine
technology gives you world-leading solutions
for managing the pharmaceutical value chain.
From high-performing automated medication
pouch packaging machines to the most advanced
management software. VMI has the tools to bring
you greater speed, accuracy, and flexibility as you
develop a new kind of pharmaceutical strategy.
XchangeLabs
www.xchangelabs.com
Revolutionize your clinical pharmacy practice with
OpalCare® by XchangeLabs, meticulously crafted for
modern pharmacist demands. Experience a powerful
tool that not only amplifies your revenue potential
but also elevates patient care outcomes. OpalCare
seamlessly integrates with electronic health records
(EHRs), health information exchanges (HIEs), and retail
and LTC pharmacy systems, ensuring a cohesive
patient journey. Streamline your workflow and
enhance real-time collaboration among healthcare
professionals, saving you valuable time and ultimately
improving the overall quality of care. Unleash the
true potential of your practice with OpalCare.
Xeris Pharmaceuticals, Inc.
www.gvokeglucagon.com
Xeris Pharmaceuticals, Inc., the maker of Gvoke
HypoPen® (glucagon injection), is dedicated to
unlocking the potential of glucagon. We believe
that our technology can have a profound impact
on the lives of patients and their families. That’s
why we are proud to be the first to develop liquid
glucagon, but that’s just the beginning. We’re also
studying how our formulation technology can
impact patients with other conditions. We have a
persistent drive to pursue solutions that have the
potential to change lives. Get to know us and see
how our technology is unlocking the potential of
today’s medicines at www.xerispharma.com.
153